Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,920,988 papers from all fields of science
Search
Sign In
Create Free Account
PF 04457845
Known as:
PF-04457845
, PF04457845
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial
L. Mayo
,
A. Asratian
,
+6 authors
M. Heilig
Biological Psychiatry
2020
Corpus ID: 199577328
Highly Cited
2017
Highly Cited
2017
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474
A. C. M. van Esbroeck
,
A. P. Janssen
,
+26 authors
M. van der Stelt
Science
2017
Corpus ID: 44100153
A clue to a drug's neurotoxicity? The drug BIA 10-2474 inhibits fatty acid amide hydrolase (FAAH), a lipase that degrades a…
Expand
Highly Cited
2016
Highly Cited
2016
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
V. M. Doenni
,
J. M. Gray
,
C. Song
,
S. Patel
,
M. Hill
,
Q. Pittman
Brain, behavior, and immunity
2016
Corpus ID: 3757870
2015
2015
Deficits in spontaneous burrowing behavior in the rat bilateral monosodium iodoacetate model of osteoarthritis: an objective measure of pain-related behavior and analgesic efficacy.
L. Bryden
,
J. Nicholson
,
H. Doods
,
A. Pekcec
Osteoarthritis and Cartilage
2015
Corpus ID: 33082754
Highly Cited
2012
Highly Cited
2012
Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects.
G. Li
,
H. Winter
,
+4 authors
J. P. Huggins
British Journal of Clinical Pharmacology
2012
Corpus ID: 1752509
UNLABELLED AIMS To evaluate the pharmacology and tolerability of PF-04457845, an orally available fatty acid amide hydrolase-1…
Expand
Highly Cited
2012
Highly Cited
2012
An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective…
J. P. Huggins
,
T. Smart
,
Stephen R. Langman
,
Louise Taylor
,
T. Young
Pain
2012
Corpus ID: 25179328
Highly Cited
2012
Highly Cited
2012
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions.
O. Sasso
,
R. Bertorelli
,
+6 authors
D. Piomelli
Pharmacological Research
2012
Corpus ID: 30893437
2012
2012
Inhibitors of endocannabinoid breakdown for pain: Not so FA(AH)cile, after all
V. Marzo
Pain
2012
Corpus ID: 35159663
Highly Cited
2011
Highly Cited
2011
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor.
Douglas S. Johnson
,
C. Stiff
,
+13 authors
Kay Ahn
ACS Medicinal Chemistry Letters
2011
Corpus ID: 36786224
Fatty acid amide hydrolase (FAAH) is an integral membrane serine hydrolase that degrades the fatty acid amide family of signaling…
Expand
Highly Cited
2011
Highly Cited
2011
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain
Kay Ahn
,
Sarah E. Smith
,
+16 authors
B. Cravatt
Journal of Pharmacology and Experimental…
2011
Corpus ID: 6260447
The endogenous cannabinoid (endocannabinoid) anandamide is principally degraded by the integral membrane enzyme fatty acid amide…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE